| Year |
Citation |
Score |
| 2020 |
Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, Burger EA, Martin D, Nguyen DTN, Bénard É, Sy S, Regan C, Drolet M, Gingras G, Laprise JF, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet (London, England). PMID 32007142 DOI: 10.1016/S0140-6736(20)30157-4 |
0.41 |
|
| 2020 |
Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, Martin D, Simms KT, Bénard É, Boily MC, Sy S, Regan C, Keane A, Caruana M, Nguyen DTN, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet (London, England). PMID 32007141 DOI: 10.1016/S0140-6736(20)30068-4 |
0.413 |
|
| 2020 |
Drolet M, Brisson M. Population-level impact of human papillomavirus vaccination - Authors' reply. Lancet (London, England). PMID 31972129 DOI: 10.1016/S0140-6736(19)33158-7 |
0.331 |
|
| 2019 |
Whitworth HS, Gallagher KE, Howard N, Mounier-Jack S, Mbwanji G, Kreimer AR, Basu P, Kelly H, Drolet M, Brisson M, Watson-Jones D. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials. Vaccine. PMID 31870572 DOI: 10.1016/J.Vaccine.2019.12.017 |
0.336 |
|
| 2019 |
Humphries B, Lauzier S, Drolet M, Coyle D, Mâsse B, Provencher L, Robidoux A, Maunsell E. Wage losses among spouses of women with nonmetastatic breast cancer. Cancer. PMID 31821547 DOI: 10.1002/Cncr.32638 |
0.692 |
|
| 2019 |
Laprise JF, Chesson HW, Markowitz LE, Drolet M, Martin D, Bénard É, Brisson M. Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States. Annals of Internal Medicine. PMID 31816629 DOI: 10.7326/M19-1182 |
0.417 |
|
| 2019 |
Drolet M, Zhou Z, Sauvageau C, DeWals P, Gilca V, Amini R, Bénard É, Brisson M. Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 191: E932-E939. PMID 31451524 DOI: 10.1503/Cmaj.190274 |
0.343 |
|
| 2019 |
Drolet M, Bénard É, Pérez N, Brisson M. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet (London, England). PMID 31255301 DOI: 10.1097/Ogx.0000000000000724 |
0.397 |
|
| 2019 |
Brisson M, Drolet M. Global elimination of cervical cancer as a public health problem. The Lancet. Oncology. PMID 30795952 DOI: 10.1016/S1470-2045(19)30072-5 |
0.324 |
|
| 2018 |
Drolet M, Bénard É, Jit M, Hutubessy R, Brisson M. Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 1250-1258. PMID 30314627 DOI: 10.1016/J.Jval.2018.03.014 |
0.341 |
|
| 2018 |
Markowitz LE, Drolet M, Perez N, Jit M, Brisson M. Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs. Vaccine. PMID 29802000 DOI: 10.1016/J.Vaccine.2018.01.057 |
0.335 |
|
| 2017 |
Drolet M, Laprise JF, Brotherton JML, Donovan B, Fairley CK, Ali H, Bénard É, Martin D, Brisson M. The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation. The Journal of Infectious Diseases. PMID 28968800 DOI: 10.1093/Infdis/Jix476 |
0.362 |
|
| 2017 |
Lemieux-Mellouki P, Drolet M, Jit M, Gingras G, Brisson M. Modelling multi-site transmission of the human papillomavirus and its impact on vaccination effectiveness. Epidemics. 21: 80-87. PMID 28916210 DOI: 10.1016/J.Epidem.2017.08.001 |
0.353 |
|
| 2017 |
Looker kj, Rönn MM, Brock PM, Brisson M, Drolet M, Mayaud P, Boily M. LB1.2 What is the strength of evidence for hiv and hpv interactions? results from systematic reviews and meta-analyses of longitudinal studies Sexually Transmitted Infections. 93. DOI: 10.1136/Sextrans-2017-053264.103 |
0.316 |
|
| 2016 |
Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily MC, Smith MA, Berkhof J, Canfell K, Chesson HW, Burger EA, Choi YH, De Blasio BF, et al. Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. The Lancet. Public Health. 1: e8-e17. PMID 29253379 DOI: 10.1016/S2468-2667(16)30001-9 |
0.388 |
|
| 2016 |
Brisson M, Drolet M, Bénard É, Kreimer AR. Effect of HPV on cervical cancer screening in Alberta. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 188: 1035. PMID 27698024 DOI: 10.1503/Cmaj.1150121 |
0.378 |
|
| 2016 |
Mesher D, Soldan K, Lehtinen M, Beddows S, Brisson M, Brotherton JM, Chow EP, Cummings T, Drolet M, Fairley CK, Garland SM, Kahn JA, Kavanagh K, Markowitz L, Pollock KG, et al. Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes. Emerging Infectious Diseases. 22: 1732-1740. PMID 27648688 DOI: 10.3201/Eid2210.160675 |
0.363 |
|
| 2016 |
Laprise JF, Markowitz LE, Chesson HW, Drolet M, Brisson M. COMPARING 2- AND 3-DOSE 9-VALENT HPV VACCINE SCHEDULES IN THE U.S.: A COST-EFFECTIVENESS ANALYSIS. The Journal of Infectious Diseases. PMID 27234416 DOI: 10.1093/Infdis/Jiw227 |
0.345 |
|
| 2016 |
Drolet M, Deeks SL, Kliewer E, Musto G, Lambert P, Brisson M. Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada. Vaccine. 34: 1874-80. PMID 26954465 DOI: 10.1016/J.Vaccine.2016.02.069 |
0.36 |
|
| 2016 |
Brisson M, Laprise JF, Chesson HW, Drolet M, Malagón T, Boily MC, Markowitz LE. Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States. Journal of the National Cancer Institute. 108. PMID 26438574 DOI: 10.1093/Jnci/Djv282 |
0.379 |
|
| 2015 |
Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JM, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. The Lancet. Infectious Diseases. 15: 565-80. PMID 25744474 DOI: 10.1016/S1473-3099(14)71073-4 |
0.368 |
|
| 2015 |
Malagón T, Drolet M, Boily MC, Laprise JF, Brisson M. Changing inequalities in cervical cancer: modeling the impact of vaccine uptake, vaccine herd effects, and cervical cancer screening in the post-vaccination era. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 276-85. PMID 25380735 DOI: 10.1158/1055-9965.Epi-14-1052 |
0.416 |
|
| 2014 |
Laprise JF, Drolet M, Boily MC, Jit M, Sauvageau C, Franco EL, Lemieux-Mellouki P, Malagón T, Brisson M. Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study. Vaccine. 32: 5845-53. PMID 25131743 DOI: 10.1016/J.Vaccine.2014.07.099 |
0.37 |
|
| 2014 |
Jit M, Choi YH, Laprise JF, Boily MC, Drolet M, Brisson M. Two-dose strategies for human papillomavirus vaccination: how well do they need to protect? Vaccine. 32: 3237-42. PMID 24726246 DOI: 10.1016/J.Vaccine.2014.03.098 |
0.342 |
|
| 2014 |
Drolet M, Laprise JF, Boily MC, Franco EL, Brisson M. Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine. International Journal of Cancer. Journal International Du Cancer. 134: 2264-8. PMID 24174175 DOI: 10.1002/Ijc.28541 |
0.4 |
|
| 2013 |
Drolet M, Boily MC, Van de Velde N, Franco EL, Brisson M. Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness? Plos One. 8: e67072. PMID 23840589 DOI: 10.1371/Journal.Pone.0067072 |
0.362 |
|
| 2013 |
Brisson M, Laprise JF, Drolet M, Van de Velde N, Franco EL, Kliewer EV, Ogilvie G, Deeks SL, Boily MC. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study. Vaccine. 31: 3863-71. PMID 23830974 DOI: 10.1016/J.Vaccine.2013.06.064 |
0.385 |
|
| 2013 |
Drolet M, Boily MC, Greenaway C, Deeks SL, Blanchette C, Laprise JF, Brisson M. Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 641-52. PMID 23549400 DOI: 10.1158/1055-9965.Epi-12-1173 |
0.393 |
|
| 2013 |
Malagón T, Joumier V, Boily MC, Van de Velde N, Drolet M, Brisson M. The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: a model-based analysis. Vaccine. 31: 1740-7. PMID 23384753 DOI: 10.1016/J.Vaccine.2013.01.026 |
0.356 |
|
| 2013 |
Lauzier S, Levesque P, Mondor M, Drolet M, Coyle D, Brisson J, Masse B, Provencher L, Robidoux A, Maunsell E. Out-of-pocket costs in the year after early breast cancer among canadian women and spouses Journal of the National Cancer Institute. 105: 280-292. PMID 23349250 DOI: 10.1093/Jnci/Djs512 |
0.69 |
|
| 2013 |
Drolet M, Oxman MN, Levin MJ, Schmader KE, Johnson RW, Patrick D, Mansi JA, Brisson M. Vaccination against herpes zoster in developed countries: state of the evidence. Human Vaccines & Immunotherapeutics. 9: 1177-84. PMID 23324598 DOI: 10.4161/Hv.23491 |
0.345 |
|
| 2013 |
Brisson M, Drolet M, Malagón T. Inequalities in human papillomavirus (HPV)-associated cancers: Implications for the success of HPV vaccination Journal of the National Cancer Institute. 105: 158-161. PMID 23297040 DOI: 10.1093/Jnci/Djs638 |
0.377 |
|
| 2013 |
Owen BN, Brock PM, Baggaley RF, Butler AR, Pickles M, Brisson M, Drolet M, Boily M. P3.003 Heterosexual Anal Intercourse Among Youth: A Systematic Review and Metaanalysis Sexually Transmitted Infections. 89: A148.3-A148. DOI: 10.1136/Sextrans-2013-051184.0463 |
0.301 |
|
| 2013 |
Owen BN, Brock PM, Shubber Z, Baggaley RF, Butler AR, Pickles M, Brisson M, Drolet M, Boily M. 31. Lifetime prevalence of anal intercourse among sexually active female youth and young female sex workers: a comparative systematic review and meta-analysis Sexual Health. 10: 585. DOI: 10.1071/Shv10N6Ab31 |
0.305 |
|
| 2012 |
Van de Velde N, Boily MC, Drolet M, Franco EL, Mayrand MH, Kliewer EV, Coutlée F, Laprise JF, Malagón T, Brisson M. Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis. Journal of the National Cancer Institute. 104: 1712-23. PMID 23104323 DOI: 10.1093/Jnci/Djs395 |
0.366 |
|
| 2012 |
Malagón T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. The Lancet. Infectious Diseases. 12: 781-9. PMID 22920953 DOI: 10.1016/S1473-3099(12)70187-1 |
0.358 |
|
| 2012 |
Drolet M, Levin MJ, Schmader KE, Johnson R, Oxman MN, Patrick D, Fournier SO, Mansi JA, Brisson M. Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study. Vaccine. 30: 2047-50. PMID 22285632 DOI: 10.1016/J.Vaccine.2012.01.045 |
0.323 |
|
| 2012 |
Drolet M, Brisson M, Maunsell E, Franco EL, Coutlée F, Ferenczy A, Fisher W, Mansi JA. The psychosocial impact of an abnormal cervical smear result. Psycho-Oncology. 21: 1071-81. PMID 21695747 DOI: 10.1002/Pon.2003 |
0.62 |
|
| 2011 |
Drolet M, Brisson M, Maunsell E, Franco EL, Coutlée F, Ferenczy A, Ratnam S, Fisher W, Mansi JA. The impact of anogenital warts on health-related quality of life: a 6-month prospective study. Sexually Transmitted Diseases. 38: 949-56. PMID 21934571 DOI: 10.1097/Olq.0B013E3182215512 |
0.626 |
|
| 2011 |
Lauzier S, Levesque P, Drolet M, Coyle D, Brisson J, Mâsse B, Robidoux A, Robert J, Maunsell E. Out-of-pocket costs for accessing adjuvant radiotherapy among Canadian women with breast cancer Journal of Clinical Oncology. 29: 4007-4013. PMID 21931023 DOI: 10.1200/Jco.2011.35.1007 |
0.686 |
|
| 2011 |
Brisson M, van de Velde N, Franco EL, Drolet M, Boily MC. Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. The Journal of Infectious Diseases. 204: 372-6. PMID 21742835 DOI: 10.1093/Infdis/Jir285 |
0.367 |
|
| 2010 |
Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, Patrick D, Blanchette C, Mansi JA. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 182: 1731-6. PMID 20921251 DOI: 10.1503/Cmaj.091711 |
0.318 |
|
| 2010 |
Lauzier S, Maunsell E, Drolet M, Coyle D, Hébert-Croteau N. Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers Quality of Life Research. 19: 177-189. PMID 20094806 DOI: 10.1007/S11136-009-9575-Y |
0.646 |
|
| 2008 |
Lauzier S, Maunsell E, Drolet M, Coyle D, Hébert-Croteau N, Brisson J, Mâsse B, Abdous B, Robidoux A, Robert J. Wage losses in the year after breast cancer: Extent and determinants among Canadian women Journal of the National Cancer Institute. 100: 321-332. PMID 18314472 DOI: 10.1093/Jnci/Djn028 |
0.7 |
|
| 2007 |
Lauzier S, Maunsell E, Drolet M, Hébert-Croteau N, Brisson J, Coyle D, Masse B, Abdous B, Robidoux A, Robert J. Financial burden from wage losses after early breast cancer: Extent and determinants among Canadian women Journal of Clinical Oncology. 25: 9000-9000. DOI: 10.1200/Jco.2007.25.18_Suppl.9000 |
0.704 |
|
| 2006 |
Dorval M, Drolet M, Leblanc M, Maunsell E, Dugas MJ, Simard J. Using the impact of event scale to evaluate distress in the context of genetic testing for breast cancer susceptibility Psychological Reports. 98: 873-881. PMID 16933689 DOI: 10.2466/Pr0.98.3.873-881 |
0.641 |
|
| 2005 |
Drolet M, Maunsell E, Brisson J, Brisson C, Mâsse B, Deschênes L. Not working 3 years after breast cancer: Predictors in a population-based study Journal of Clinical Oncology. 23: 8305-8312. PMID 16219927 DOI: 10.1200/Jco.2005.09.500 |
0.699 |
|
| 2005 |
Drolet M, Maunsell E, Mondor M, Brisson C, Brisson J, Mâsse B, Deschênes L. Work absence after breast cancer diagnosis: A population-based study Cmaj. 173: 765-769. PMID 16186583 DOI: 10.1503/Cmaj.050178 |
0.705 |
|
| 2005 |
Maunsell E, Drolet M, Ouhoummane N, Robert J. Breast cancer survivors accurately reported key treatment and prognostic characteristics Journal of Clinical Epidemiology. 58: 364-369. PMID 15862722 DOI: 10.1016/J.Jclinepi.2004.09.005 |
0.66 |
|
| 2005 |
Lauzier S, Maunsell E, De Koninck M, Drolet M, Hébert-Croteau N, Robert J. Conceptualization and sources of costs from breast cancer: Findings from patient and caregiver focus groups Psycho-Oncology. 14: 351-360. PMID 15386763 DOI: 10.1002/Pon.851 |
0.688 |
|
| 2004 |
Maunsell E, Drolet M, Brisson J, Brisson C, Mâsse B, Deschênes L. Work situation after breast cancer: Results from a population-based study Journal of the National Cancer Institute. 96: 1813-1822. PMID 15601637 DOI: 10.1093/Jnci/Djh335 |
0.705 |
|
| 2002 |
Maunsell E, Drolet M, Brisson J, Robert J, Deschênes L. Dietary change after breast cancer: Extent, predictors, and relation with psychological distress Journal of Clinical Oncology. 20: 1017-1025. PMID 11844825 DOI: 10.1200/Jco.20.4.1017 |
0.674 |
|
| Show low-probability matches. |